SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-24-012456
Filing Date
2024-04-18
Accepted
2024-04-18 16:56:18
Documents
19
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A tgtx20240410_pre14a.htm   iXBRL PRE 14A 930006
6 capvsnetincomesmall.jpg GRAPHIC 35926
7 picture1capvstsrsmall.jpg GRAPHIC 37185
8 picture5capvscsfmsmall.jpg GRAPHIC 34453
9 tgtxlogo01.jpg GRAPHIC 6027
  Complete submission text file 0001437749-24-012456.txt   2007527

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20231231.xsd EX-101.SCH 7001
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20231231_def.xml EX-101.DEF 9262
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20231231_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20231231_pre.xml EX-101.PRE 8849
22 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20240410_pre14a_htm.xml XML 199884
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32639 | Film No.: 24854889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)